The device, called EndoStim®, is a small neurostimulator that is implanted under the skin of the abdomen ... This double-blinded, randomized control trial will place the device in all study patients.

The study enrolled 68 participants who were implanted with either subthalamic ... reported positive data from a clinical trial showing that its neurostimulation device can help alleviate symptoms ...

Onward Medical has successfully implanted ... neurostimulation. Dr Jocelyne Bloch, who performed the implant, said the ...

The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its ...

A rheumatoid arthritis patient has become the first of five to be implanted ... the neurostimulator and the development of the controlling software. Now, the start of human trials now means ...

Purpose of Study: The Food and Drug Administration (FDA) gave approval of the Humanitarian Device Exemption (HDE) a Humanitarian use device for Medtronic Reclaim Therapy to Medtronic, Inc. (HDE# ...

Occipital nerve stimulation (ONS) is an effective treatment for primary headache. However, current methods of ONS involve electrodes placed across the occipital nerve that are connected to a ...

A Texas man agreed to pay $948,359 to resolve allegations he submitted false claims for the surgical implantation of neurostimulator electrodes, the Justice Department announced Monday. According to ...

Image credit: Prostock-studio via Shutterstock Mainstay Medical’s one-year study of its neurostimulation system for the treatment ... in 2020. A surgically implanted device, ReActiv8 is comprised of a ...

This led to cost savings of $13,776 per patient in the 12-month post-implant ... Nalu Neurostimulation System for PNS is not intended to treat pain in the craniofacial region. The trial devices ...

Cortigent, Inc. (CRTG) plans to raise $15 million in an initial public offering on Friday, January 24th, IPO Scoop reports. The company will issue 1,500,000 shares at $10.00 per share. Cortigent, Inc.